Segments - Enteral Feeding Devices Market by Product Type (Enteral Feeding Tubes, Enteral Feeding Pumps, Enteral Feeding Bags, Administration Sets, Enteral Syringes, and Consumables), By Age Group (Adults and Pediatric), By End User (Hospitals, Home Care Settings, And Ambulatory Care Settings), By Application (Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, Hypermetabolism, Critical Care, and Others) and Region (North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa)
The Global Enteral Feeding Devices market was estimated at USD 4,474.2 Million in 2023 and is anticipated to reach USD 7,065.9 Million by 2031, expanding at a CAGR of 5.9% during the forecast period.
An enteral feeding device is used to deliver nutrition directly to the stomach or intestines through a thin, flexible tube. Additionally, its known as tube feeding, enteral nutrition is administered to patients who cannot maintain adequate oral intake of food or nutrition to meet their nutritional needs.
Enteral feeding devices can be placed through the nose (nasogastric and nasojejunal tubes) or mouth (orogastric tubes) or surgically implanted into the stomach (gastrostomy tubes) or intestines (jejunostomy tubes).
The outbreak of Coronavirus disease in 2019 (COVID-19) restrained the global economy, created global interdependence, and challenged the governments of various nations. The pandemic raised concerns among economies and businesses by shifting focus on the online supply of consumer electronic gadgets, automotive components, and medical devices, thereby creating manufacturing issues. The COVID-19 outbreak is an unsurpassed public health emergency that impacted almost every industry. The long-term effects of the pandemic are expected to affect the growth of various industries during the forecast period, especially across Eastern Europe, the European Union, the US, and Eastern & Central Asia.
The COVID-19 pandemic had a significant impact on the supply and demand for medical devices, including enteral feeding devices. In the impacted countries, elective surgeries have been delayed; however, international demand for COVID-19-related items, such as personal protective equipment (PPE), has surged. Manufacturers have to modify their supply chain to satisfy consumer demands and maintain low shipping costs for medical devices, as COVID-19 continues to have an impact.
Medical device companies focused on immediate crisis response, keeping staff safe, ensuring business continuity, and dealing with the rapid changes in the healthcare ecosystem. This also included responding to fast shifts in care location and patient conduct.
Short-term planning impacted a company survival during the pandemic and shaped its long-term recovery for a potentially different future in the medical device business. Medical device firms have transformed the way they communicate with and serve their customers.
The global enteral feeding devices market is expected to witness significant growth in the coming years, driven by the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. Here are some potential impacts of AI on the enteral feeding devices market:
Personalized nutrition planning: AI-powered algorithms can analyze patient data, such as nutritional needs, medical history, and genetic information, to create personalized nutrition plans for patients with enteral feeding needs. This can lead to improved patient outcomes, reduced healthcare costs, and enhanced patient satisfaction.
Intelligent pump monitoring: AI-enabled pumps can monitor patient data in real-time, detecting any deviations from the prescribed feeding regimen and alerting healthcare professionals to take prompt action. This can help prevent complications, such as clogging or occlusion, and ensure timely intervention.
Predictive maintenance: AI-powered sensors can monitor the performance of enteral feeding devices in real-time, predicting potential issues before they occur. This can reduce downtime, minimize repairs, and extend the lifespan of devices.
Automated data analysis: AI algorithms can analyze large amounts of data from various sources, including electronic health records, medical devices, and wearables. This can help identify trends, patterns, and correlations that inform clinical decision-making and improve patient care.
Virtual coaching: AI-powered chatbots or virtual assistants can provide personalized coaching and support to patients with enteral feeding needs, helping them manage their nutrition plans and adhere to their treatment regimens.
Streamlined documentation: AI-powered tools can automate documentation processes, reducing the administrative burden on healthcare professionals and improving data accuracy.
Enhanced patient engagement: AI-powered platforms can facilitate patient engagement through personalized content, reminders, and alerts, empowering patients to take a more active role in their care.
Remote monitoring: AI-powered remote monitoring systems can enable real-time monitoring of patients with enteral feeding needs, allowing healthcare professionals to respond promptly to any issues or concerns.
Data-driven decision-making: AI analytics can provide insights on patient outcomes, treatment efficacy, and device performance, enabling data-driven decision-making and improving overall healthcare outcomes.
Health spending is defined as the final consumption of healthcare goods and services (that is current health expenditure), which includes personal healthcare (curative care, rehabilitative care, long-term care, ancillary services, and medical goods) and collective services (prevention and public health services, as well as health administration). However, health spending excludes investment spending. It is funded by a combination of government funding and mandatory health insurance (government/compulsory), and optional health insurance and private money, such as out-of-pocket contributions by households.
As the number of surgeries increases, so does the need for post-operative nutrition support. Enteral feeding devices play a crucial role in providing adequate nutrition to patients who cannot consume food orally following surgery. This increased the demand for post-operative nutrition support, which can boost the demand for enteral feeding devices.
The escalation in chronic diseases, such as cancer, gastrointestinal disorders, and neurological conditions, drives the demand for enteral feeding devices. Patients suffering from chronic illnesses often require nutritional support that can be effectively provided through enteral feeding devices, leading to increased utilization of these devices. For instance, according to a report by the United Nations, that by 2030, the global burden of disease is projected to reach 56% and chronic illnesses are likely to claim 70% of death by 2030.
Rise in the global elderly population is a pivotal factor boosting the growth of the enteral feeding devices market. The high prevalence of age-related illnesses such as dysphagia, stroke, and neurological disorders that affect swallowing. Hence, enteral feeding devices play a crucial role in providing nutritional support to individuals with these conditions, thereby driving the demand for such devices.
According to a WHO report, one in every six persons in the world are expected to be 60 or older by 2030. The share of the population aged 60 years or older is going to rise from 1 billion in 2020 to 1.4 billion by 2030. Surgical procedures often result in challenges related to oral intake post-surgery due to factors such as pain, reduced appetite, or swallowing difficulties. Enteral feeding devices play a crucial role in providing essential nutrition to patients recovering from surgical interventions, promoting fast recovery and reduced complications associated with inadequate nutrition intake after surgery. For instance, according to an article published in National Library of Medicine, every year, 310 million major surgeries are performed around the world, with the US accounting for 40 to 50 million and Europe for 20 million.
Complications such as initial placement issues, mechanical problems, clinical challenges, and nutritional concerns can lead to healthcare costs for patients and healthcare providers. These added expenses deter some individuals or institutions from opting for enteral feeding devices, affecting sales.
Serious complications associated with enteral feeding devices, such as aspiration, tube dislodgment, or infections, can raise safety concerns among patients and healthcare professionals. These concerns influence decision-making regarding the use of enteral feeding devices, potentially reducing sales.
Complications related to enteral feeding devices, even if minor in most cases, can affect the overall perception of these products in the market. Negative perceptions stemming from complications can lead to decreased trust and lower demand for enteral feeding devices, thereby declining the sales of enteral feeding devices. The type and frequency of complications during enteral nutrition may be associated with diet formulation and distribution, and the underlying condition.
The three basic types of enteral nutrition complications are gastrointestinal, mechanical, and metabolic. GI problems are commonly reported. Enteral nutrition therapy should be used with caution, but once done, regular monitoring of patients is an effective way to prevent complications and side effects.
Growing healthcare sectors in emerging economies, such as those in the Asia Pacific, are increasing the adoption of advanced medical technologies. Furthermore, rising awareness about treatment options and the prevalence of chronic disorders such as cancer, drives the adoption of enteral feeding devices, creating opportunities for market players to increase sales.
Improvements in healthcare systems in countries across Asia, and growing awareness about treatment options among patients, have increased the adoption of advanced nutritional therapies. This trend boosts the adoption of enteral feeding devices in emerging economies, presenting opportunities for market players to boost sales. The demand for enteral feeding devices has shifted from hospital treatment to home enteral nutrition. This trend is expected to continue in the coming years.
The growth of healthcare infrastructure in countries such as India, South Africa, and China, is attributed to factors such as a rapidly increasing geriatric population, rising per capita incomes, and heightened awareness among individuals. This, in turn, is boosting the need for enhancing healthcare facilities.
Increase in investments in healthcare infrastructure offers growth opportunities in the enteral feeding device market by expanding the applications of these devices within healthcare industries.
The report on the Global Enteral Feeding Devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Enteral Feeding Devices Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
By Product Type (Enteral Feeding Tubes, Enteral Feeding Pumps, Enteral Feeding Bags, Administration Sets, Enteral Syringes, and Consumables), By Age Group (Adults and Pediatric), By End User (Hospitals, Home Care Settings, And Ambulatory Care Settings), By Application (Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, Hypermetabolism, Critical Care, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Fresenius SE & Co. KGaA; Avanos Medical, Inc; Danone; Nestlé; Cardinal Health Inc; BD; Baxter International Inc.; B. Braun SE; Moog Inc.; Vygon; Boston Scientific Corporation; CONMED Corporation; Medela; Cook Group; Dynarex Corporation and Others. |
Based on product type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral feeding bags, administration sets, enteral syringes, and consumables. Enteral feeding tubes segment is further divided into enterostomy feeding tubes, nasoenteric feeding tubes and oroenteric feeding tubes. The enterostomy feeding tubes segment was valued at USD 995.0 million in 2022 and is projected to expand at a CAGR of 6.1% during the forecast period, owing to the rising demand for enteral feeding therapies in neonates and infants with conditions such as preterm births and genetic disorders.
Based on age group, the enteral feeding devices market is bifurcated into adults and pediatric. The adults segment is projected to expand at a CAGR of 6.0% during the forecast period, as adults are more likely to develop chronic diseases and disorders, including cancer, multiple sclerosis, liver disease, motor neuron disease, Parkinson's disease, sepsis, anorexia, cystic fibrosis, dementia, and inflammatory bowel disease. The growing elderly population as well as the rising prevalence of chronic diseases have increased the demand for good nutrition management to help people maintain their weight, recover fast, and respond better to treatments. For instance, according to a WHO report published in 2022, globally, the share of people over 60 years of age is expected to almost double from 12% to 22% between 2015 and 2050.
Based on end user, the enteral feeding devices market is bifurcated into hospitals, home care settings, and ambulatory care settings. The hospitals segment is projected to expand at a CAGR of 6.0% during the forecast period. Hospitals, being a primary healthcare provider, experience a surge in the demand for enteral feeding devices, due to the high number of patients seeking nutritional support. Patients with conditions such as cancer, gastrointestinal disorders, and neurological issues often require enteral nutrition, leading to an increased need for these devices in hospital settings with high patient footfall. This is expected to increase the demand for enteral feeding devices during the forecast period.
Based on application, the enteral feeding devices market is segmented into oncology, gastrointestinal diseases, neurological disorders, diabetes, hypermetabolism, critical care, and others. The oncology segment is projected to expand at a CAGR of 6.2% during the forecast period, owing to the increase in global cancer cases that has led to a high demand for nutritional support to manage malnutrition and improve patient outcomes. Moreover, enteral feeding devices are increasingly being used to provide essential nutrients and fluids to oncology patients, contributing to the rising use of these devices. For instance, according to a report by WHO in 2024, over 35 million more cancer cases are expected in 2050, up 77% over the estimated 20 million in 2022.
On the basis of region, the Global Enteral Feeding Devices market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA).
The market in North America is projected to expand at a CAGR of 6.0% during the forecast period, owing to the advanced healthcare systems with well-established reimbursement policies and healthcare infrastructure in the region. Europe accounted for 24.06% share of the market in 2022. The market in Europe is projected to expand at a CAGR of 5.8% in the coming years, due to the rising Incidence of premature births across the region. For instance, according to the European Lung Foundation, every year, almost 15 million babies are born prematurely across the globe, with approximately 500,000 in Europe. This is anticipated to increase the demand for enteral feeding devices during the forecast period. The market in Asia Pacific is projected to expand at a CAGR of 6.2% during the forecast period, owing to the high incidence of cancer and gastrointestinal diseases in the region due to high prevalence of H. pylori infection, certain dietary practices, smoking habits, and strong alcohol intake.
In-depth Analysis of the global Enteral Feeding Devices Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Enteral Feeding Devices Market performance
Manufacturers operating in the global Enteral Feeding Devices market include Fresenius SE & Co. KGaA; Avanos Medical, Inc; Danone; Nestlé; Cardinal Health Inc; BD; Baxter International Inc.; B. Braun SE; Moog Inc.; Vygon; Boston Scientific Corporation; CONMED Corporation; Medela; Cook Group; Dynarex Corporation and Others.
Market players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the Global Enteral Feeding Devices market.
In February 2024, Fresenius SE & Co. KGaA collaborated with the European Society for Intensive Care Medicine (ESICM). This partnership is founded on two important pillars to support educational efforts and professional growth of medical professionals as well as to leave a long-lasting impact on the future of healthcare.
In November, 2023, Cardinal Health Inc announced the US launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.
In November, 2023, BD launched a new and advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices. The SiteRite 9 Ultrasound System is an all-in-one system designed with a user-friendly experience on an updated 15.6-inch touch screen with enhanced image quality. It supports clinicians during the vascular access device insertion process.
In July 2022, BD announced its acquisition of Parata Systems. Parata Systems advances the company’s transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions. These solutions power a growing network of pharmacies to reduce costs, enhance patient safety, and improve the patient experience for retail, hospital, and long-term care pharmacies.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The global Enteral Feeding Devices market is driven by a combination of factors that are expected to fuel its growth in the coming years. One of the primary drivers is the increasing prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological disorders, which often require enteral nutrition. Moreover, the government initiatives and investments in healthcare infrastructure are also driving the growth of the market. Overall, the combination of these factors is expected to drive the growth of the global Enteral Feeding Devices market over the forecast period.
According to this Growth Market Reports report, the Global Enteral Feeding Devices market is likely to register a CAGR of 5.9% during the forecast period 2023-2031, with an anticipated valuation of USD 7,065.9 Million by the end of 2031.
The hospitals segment is projected to expand at a CAGR of 6.0% during the forecast period. Hospitals, being a primary healthcare provider, experience a surge in the demand for enteral feeding devices, due to the high number of patients seeking nutritional support. Patients with conditions such as cancer, gastrointestinal disorders, and neurological issues often require enteral nutrition, leading to an increased need for these devices in hospital settings with high patient footfall. This is expected to increase the demand for enteral feeding devices during the forecast period.
Rising GDPs of emerging economies, growth in healthcare industry, government policies, R&D activities, healthcare expenditure are expected to act as macroeconomic factors for the market.
Fresenius SE & Co. KGaA; Avanos Medical, Inc; Danone; Nestlé; Cardinal Health Inc; BD; Baxter International Inc.; B. Braun SE; Moog Inc.; Vygon; Boston Scientific Corporation; CONMED Corporation; Medela; Cook Group; Dynarex Corporation and Others.
The outbreak of coronavirus disease in 2019 (COVID-19) hampered global economy, created global interdependence, and challenged governments of many nations. The long-term effects of the pandemic are expected to hamper various industries during the forecast period, especially across Eastern Europe, the European Union, Eastern & Central Asia, and the US. The pandemic halted the manufacturing and transportation services that led to disturbance in the supply chain of various therapy’s, including global enteral feeding devices.
In addition to market size (in USD Million) company market share (in % for the base year 2023) is available in the report. Moreover, additional data analysis can be provided on request.
The base year considered for the global Enteral Feeding Devices market report is 2022. The complete analysis period is 2021 to 2031, wherein, 2016, and 2022 are the historic years, and the forecast is provided from 2023 to 2031.